These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18418922)

  • 21. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders?
    Castilloux J; Noble A; Faure C
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):272-8. PubMed ID: 18376243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visceral hypersensitivity in endometriosis: a new target for treatment?
    Issa B; Onon TS; Agrawal A; Shekhar C; Morris J; Hamdy S; Whorwell PJ
    Gut; 2012 Mar; 61(3):367-72. PubMed ID: 21868492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral analgesics: drugs with a great potential in functional disorders?
    Bradesi S; Herman J; Mayer EA
    Curr Opin Pharmacol; 2008 Dec; 8(6):697-703. PubMed ID: 18786654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary on peripheral and central contributions to hyperalgesia in irritable bowel syndrome.
    Mayer EA
    J Pain; 2006 Aug; 7(8):539-41; discussion 542-3. PubMed ID: 16885009
    [No Abstract]   [Full Text] [Related]  

  • 25. Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders.
    Faure C; Wieckowska A
    J Pediatr; 2007 Jan; 150(1):66-71. PubMed ID: 17188617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptom expression in pain-predominant functional bowel syndrome: is visceral hyperalgesia the whole truth?
    Shapiro MS; Olden KW
    Am J Gastroenterol; 2000 Apr; 95(4):862-3. PubMed ID: 10763924
    [No Abstract]   [Full Text] [Related]  

  • 27. Irritable bowel syndrome: focus on otilonium bromide.
    Boeckxstaens G; Clavé P; Corazziari ES; Tack J
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):131-7. PubMed ID: 24417261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End points in irritable bowel syndrome.
    Mangel AW; Fehnel SE
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):293-5. PubMed ID: 21651345
    [No Abstract]   [Full Text] [Related]  

  • 29. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.
    Klooker TK; Braak B; Koopman KE; Welting O; Wouters MM; van der Heide S; Schemann M; Bischoff SC; van den Wijngaard RM; Boeckxstaens GE
    Gut; 2010 Sep; 59(9):1213-21. PubMed ID: 20650926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    Ceuleers H; Van Spaendonk H; Hanning N; Heirbaut J; Lambeir AM; Joossens J; Augustyns K; De Man JG; De Meester I; De Winter BY
    World J Gastroenterol; 2016 Dec; 22(47):10275-10286. PubMed ID: 28058009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of functional gastrointestinal disorders associated with abdominal pain.
    Hyams JS
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41 Suppl 1():S47-8. PubMed ID: 16131968
    [No Abstract]   [Full Text] [Related]  

  • 32. Somatic pain sensitivity in children with recurrent abdominal pain.
    Zohsel K; Hohmeister J; Flor H; Hermann C
    Am J Gastroenterol; 2008 Jun; 103(6):1517-23. PubMed ID: 18510619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of N-butylscopolammonium bromide and butorphanol tartrate for analgesia using a balloon model of abdominal pain in ponies.
    Boatwright CE; Fubini SL; Grohn YT; Goossens L
    Can J Vet Res; 1996 Jan; 60(1):65-8. PubMed ID: 8825997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Irritable bowel treatment].
    Fassov J; Fynne L; Krarup AL
    Ugeskr Laeger; 2016 Aug; 178(35):. PubMed ID: 27592867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: a pilot study.
    Vejdani R; Shalmani HR; Mir-Fattahi M; Sajed-Nia F; Abdollahi M; Zali MR; Mohammad Alizadeh AH; Bahari A; Amin G
    Dig Dis Sci; 2006 Aug; 51(8):1501-7. PubMed ID: 16868824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A method for non-medicamentous treatment of irritated bowel syndrome].
    Sobin DIu; Korepanov AM
    Vopr Kurortol Fizioter Lech Fiz Kult; 2009; (3):19-22. PubMed ID: 19639692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A response to Farup and Bytzer. Tegaserod Nordic trial.
    Nyhlin H; Hunt R
    Scand J Gastroenterol; 2004 Aug; 39(8):803-4. PubMed ID: 15513374
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of pain symptoms in irritable bowel syndrome patients.
    Gupta V; Moshiree B; Verne GN
    Drugs Today (Barc); 2004 Oct; 40(10):829-36. PubMed ID: 15605117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alverine citrate, simeticone, and Rome III irritable bowel syndrome.
    Ford AC
    Aliment Pharmacol Ther; 2010 Apr; 31(7):767-8; author reply 768-9. PubMed ID: 20415841
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of irritable bowel syndrome].
    Németh AM
    Orv Hetil; 2004 Jul; 145(30):1573-5. PubMed ID: 15382621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.